amfAR Funds Dr. Matthias Kretzler’s Crucial Research on New Treatments for COVID-19
A new grant will allow Dr. Matthias Kretzler and his team to study the potential of a class of therapeutics to treat kidney cells in COVID-19 patients.
A new grant will allow Dr. Matthias Kretzler and his team to study the potential of a class of therapeutics to treat kidney cells in COVID-19 patients.
Strategies to reduce severe diabetic foot infections and complications during epidemics (STRIDE)
Researchers found many instances of respiratory failure and kidney injury, but not heart failure, among COVID-19 patients admitted to ICUs across the country.
In addition to his diabetes research, Dr. Callaghan seeks to improve the efficiency in neurologic testing. Here he examined how a change to Medicare's nerve conduction study reimbursement policy in 2013 has affected the utilization, payments and patient access to the the procedure, which measures the speed at which an electrical impulse moves
While Catrina Robinson, PhD , is the most recent addition to the NeuroNetwork for Emerging Therapies roster of scientists, she has a long-standing relationship with Director Eva L. Feldman, M.D., Ph.D.
Over the last 100 years, we contend the subspeciality of neuromuscular disorders leads the neurologic community in the most important achievements: discovering the genetic etiology of previously untreatable neuromuscular disorders and turning these discoveries into therapies.
Dr. Eva Feldman and Dr. Vijay Viswanathan, a recent addition to the NeuroNetwork for Emerging Therapies and head of India’s M.V. Hospital for Diabetes, published new findings about diabetes and neuropathy in India.
One of the rising stars of the NeuroNetwork for Emerging Therapies, Dr. Evan Reynolds, gives a crash course on the use of biostatistics in our research.
In a Michigan Medicine Blog , Dr. Brian Callaghan discusses his clinical research of diabetes and obesity, which has demonstrated that, in addition to peripheral nerve damage, can also cause cognitive dysfunction, affecting thinking,
A new study in Mayo Clinic Proceedings by Drs. Brian Callaghan, Eva Feldman and Evan Reynolds shows that central obesity - waist circumference around the abdomen - is associated with neuropathy.
Dr. Eva Feldman shares her expertise of how environmental chemical exposures impact brain health and disease, particularly in ALS, at the 2020 Environmental Neuroscience Workshop.